ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,247Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 25

$512K Total Retail Price of All Prescriptions

Rank: 5 out of 25

360 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
26% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 360 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 360 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 10,237 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 27.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
WARFARIN SODIUM 503 503 1 8
FUROSEMIDE 460 460 2 3
LEVOTHYROXINE SODIUM 416 416 3 2
SIMVASTATIN 345 345 4 1
CITALOPRAM HBR 302 302 5 20
DONEPEZIL HCL 299 299 6 11
LISINOPRIL 265 265 7 4
AMLODIPINE BESYLATE 250 248 8 7
METOPROLOL TARTRATE 245 245 9 9
HYDROCODONE-ACETAMINOPHEN 235 232 S3 10 6
ENALAPRIL MALEATE 230 230 11 30
NAMENDA 227 227 12 22
POTASSIUM CHLORIDE 216 216 13 15
OMEPRAZOLE 186 186 14 5
METOPROLOL SUCCINATE 170 170 15 14
PANTOPRAZOLE SODIUM 120 120 16 32
MIRTAZAPINE 119 119 17 26
RISPERIDONE 109 109 18 21
QUETIAPINE FUMARATE 102 101 19 35
PREDNISONE 101 101 20 41
ALENDRONATE SODIUM 99 99 21 18
FLUTICASONE PROPIONATE 97 97 22 47
ATENOLOL 97 97 22 31
TRAZODONE HCL 96 95 24 36
CLOPIDOGREL 96 96 24 29
SERTRALINE HCL 95 95 26 16
GABAPENTIN 92 92 27 12
CARVEDILOL 89 89 28 28
ESCITALOPRAM OXALATE 81 81 29 79
LOSARTAN POTASSIUM 69 69 30 34
ZOLPIDEM TARTRATE 66 66 31 39
HYDROCHLOROTHIAZIDE 65 65 32 17
ALLOPURINOL 65 65 32 59
TAMSULOSIN HCL 64 64 34 27
LEVETIRACETAM 61 61 35 62
NITROFURANTOIN MONO-MACRO 60 60 36 177
METFORMIN HCL 59 59 37 10
GLIPIZIDE 59 59 37 48
FAMOTIDINE 57 57 39 38
PRAVASTATIN SODIUM 55 55 40 44
HYDRALAZINE HCL 55 55 40 63
OXYBUTYNIN CHLORIDE ER 52 52 42 46
TRIAMTERENE-HCTZ 52 52 42 92
PLAVIX 50 50 44 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.